The Aim of This Study is to Demonstrat That Vacuum-assisted Closure Versus Conventional Wound Closure Enables to Diminish Local Complications After Lymph Node Dissection in Patients With Metastatic Skin Tumors

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

90 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-01-01

Study Completion Date

2020-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study, we compared a negative pressure wound therapy, versus a conventional dressing in order to evaluate the most efficient wound therapy closure after axillary and inguinal lymph nodes dissections in the management of metastatic skin tumors. A vacuum assisted closure therapy should prevent these comorbidities.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Preventing Seroma Formation After Axillary Lymph Node Dissection for Breast Cancer by Early Vacuum Assisted Closure

NCT01731769

Breast Neoplasms

UNKNOWN NA

Combination of Lymphatico-venular Anastomosis and Liposuction to Treat Cancer-related Lymphedema

NCT05025982

Description of an Effective Surgical Strategy to Treat Cancer-related Lymphedema Combination of LVA and Liposuction Guarantees Long Lasting Results

UNKNOWN

Evaluation Of Lymph Nodes After Neoadjuvant Chemotherapy

NCT02752009

Breast Cancer

WITHDRAWN NA

Axillary Node Dissection w or w/o LVB in Node Positive Breast Cancer Patients

NCT05970107

Node-positive Breast Cancer

NOT_YET_RECRUITING NA

Supermicrosurgical Lymphaticovenous Anastomosis for Prevention of Upper Limb Lymphedema

NCT07026292

Breast Cancer-Related Lymphedema Lymphedema Breast Cancer Invasive

NOT_YET_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Lymphorrhoea, lymphedema and lymphocyte are significant and common complications after axillary and inguinal lymph nodes dissections. A vacuum assisted closure therapy should prevent these comorbidities. In this study, we compared PREVENA, a negative pressure wound therapy, versus conventional dressings. We evaluated the wound complications at the seventh day, the thirtieth day and at this end of the first year after surgery. It is a retrospective study of about ninety lymph nodes dissections among with there were seventy times the use of a negative pressure wound therapy, PREVENA.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Melanoma Skin Cancer Epidermoid Carcinoma Neuroendocrine Carcinoma Lymph Node Metastases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PREVENA

A vacuum wound closure therapy like PREVENA is applied after axillary or inguinal lymph node dissection in the management of metastatic skin tumors

PREVENA

Intervention Type DEVICE

A negative pressure wound closure therapy is used after lymph node dissection

NON PREVENA

A conventional wound closure is applied after axillary or inguinal lymph node dissection in the management of metastatic skin tumors

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

PREVENA

A negative pressure wound closure therapy is used after lymph node dissection

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* major patient affected by a metastatic skin tumors
* the primitive skin tumor is either a mélanoma, either squamous cell carcinoma , or a neuroendocrine tumor